Pharmaceutical MDL Attorneys

PHARMACEUTICAL LITIGATION ATTORNEY

Pharmaceutical Multidistrict Litigation Attorneys

When prescription drugs cause widespread harm, individual lawsuits are rarely enough. Stag Liuzza represents clients nationwide in large-scale pharmaceutical multidistrict litigation, holding drug manufacturers accountable for dangerous products, undisclosed risks, and corporate misconduct. Our focus is on complex cases where science, evidence, and national coordination matter.

What Is Pharmaceutical Multidistrict Litigation?

Multidistrict litigation is a federal process that consolidates similar lawsuits from across the United States into a single court for coordinated discovery and pretrial proceedings. MDLs are commonly used in pharmaceutical cases where:

A drug causes similar injuries to many people
Scientific and medical evidence overlaps across cases
Centralized discovery promotes efficiency and consistency

Pharmaceutical MDLs allow courts to evaluate complex evidence, corporate conduct, and regulatory failures in a structured way. Individual cases remain separate, but key issues are addressed collectively.

Why Pharmaceutical MDLs Matter

Large pharmaceutical settlements rarely happen by accident. Many of the largest drug settlements in U.S. history involved manufacturers that:

Promoted drugs for unapproved uses
Failed to report adverse safety data to regulators
Prioritized profits over patient safety

Multidistrict litigation plays a critical role in uncovering internal documents, corporate decision-making, and the full scope of patient harm. For injured individuals, these cases offer a pathway to accountability when harm occurs on a national scale.

Types of Pharmaceutical Cases We Handle

Dangerous and Defective Drugs

Failure to Warn

Off-Label Promotion

Hormone-Based and Long-Term Exposure Drugs

Emerging Mass Tort Investigations

HOW PFAS CONTAMINATES OUR COMMUNITIES

Holding Drug Manufacturers Accountable on a National Scale

Pharmaceutical litigation often involves widespread harm caused by drugs that were improperly tested, aggressively marketed, or released without adequate safety warnings. These cases are rarely isolated. When a prescription drug injures thousands of patients across the country, the litigation is typically consolidated into multidistrict litigation (MDL) in federal court.

Stag Liuzza has extensive experience handling complex, high-stakes litigation involving pharmaceutical misconduct, toxic exposure, and corporate failures to disclose known risks. Our firm represents individuals harmed by dangerous drugs while working alongside national leadership counsel in large-scale MDL proceedings.

Our Approach to Pharmaceutical Litigation

Stag Liuzza approaches pharmaceutical multidistrict litigation with the understanding that these cases are won through preparation, science, and persistence.

We work closely with:

Medical experts
Epidemiologists and toxicologists
National MDL leadership teams

Our attorneys are experienced in evaluating complex medical records, understanding scientific causation, and presenting evidence in cases involving widespread harm.

PHARMACEUTICAL LITIGATION

Current and Recent Pharmaceutical MDL Focus Areas

Our firm is actively involved in pharmaceutical litigation involving drugs that have affected patients nationwide, including:

Depo-Provera lawsuits involving alleged links to brain tumors and long-term health risks
Defective drugs and medical devices associated with serious injuries
Investigations into pharmaceutical companies accused of withholding safety data or misleading the public

These cases often involve years of internal corporate knowledge, complex medical causation, and extensive discovery.

Why Choose Stag Liuzza as Your Pharmaceutical MDL Attorneys?

Stag Liuzza handles pharmaceutical MDL cases with a focus on complex science, national coordination, and corporate accountability. We work alongside MDL leadership and medical experts to pursue high-impact litigation against drug manufacturers when widespread harm occurs.

If you believe a prescription drug caused serious harm, the next step is understanding whether your case may be part of a larger pharmaceutical MDL. Stag Liuzza reviews potential claims nationwide and evaluates whether injuries align with ongoing or emerging litigation. Speaking with an experienced pharmaceutical litigation team can help you understand your options and whether action is warranted.

TRIAL VICTORY

Results That Speak

$12.5 Billion

3M settlement for public drinking water systems

In March 2024, 3M finalized a settlement of up to $12.5 billion for U.S. public water suppliers to address PFAS contamination. The agreement covers water systems with current or future detections of "forever chemicals," with funds supporting testing, filtration, and infrastructure improvements.

$1.056 Billion

Exxon Mobil Corp. v. Grefer

Jury verdict for property owners whose land was contaminated with radioactive materials from oil and gas operations.

$15 Million

Verdict for Injured Pipeyard Worker

Verdict for pipeyard worker who contracted lung cancer from exposure to Radium-226 and other radioactive materials.

$6 Million

Settlement for Commercial Auto Injury

Settlement for commercial auto injury case involving a large insurance company.

View More Case Successes

No fee unless we win. Past results do not guarantee similar outcomes.

Our Attorneys

Meet the Team

With decades of combined experience in environmental law, toxic torts, and complex litigation, Stag Liuzza's attorneys have the expertise to take on the most challenging cases.

View Full Bio

Michael G. Stag

CEO & Managing Partner

Over $16 billion in settlements and more than $1 billion in jury verdicts recovered for clients. Pioneered the field of oilfield cleanup litigation. Appointed by judges to leadership for several nationwide litigations.

View biography

View Full Bio

Ashley M. Liuzza

COO & Partner

Appointed co-lead class counsel in major environmental cases. Extensive PFAS litigation experience. Helps people who developed meningioma as a result of being prescribed Depo-Provera.

View biography

View Full Bio

Merritt Cunningham

Partner

Leads the pharmaceutical and medical device division. Extensive MDL and mass tort experience. Represents thousands of firefighters harmed by PFAS exposure.

View biography

View Full Bio

Matthew D. Rogenes

Partner

Partner and trial lawyer. Trial and settlement experience in trucking cases and maritime personal injury. Recently recovered over $20 million for clients.

View biography

READY TO TALK?

If you or a loved one has suffered due to a dangerous drug or defective medical product, our team is here to help. Let’s discuss your case.

Get in Touch

Contact Stag Liuzza

Ready to discuss your case? Reach out for a free, confidential consultation. We respond to all inquiries within 24 hours.

Office

One Canal Place
365 Canal Street, Suite 2850
New Orleans, LA 70130

Phone

(504) 593-9600